|
MORE...
International Financial Reporting Standards: Considerations for Not-for-Profit Healthcare Organizations
OCTOBER 10
Healthcare systems need to consider potential IFRS implications so they can communicate appropriately with board members, payors, ratings agencies, and potential bondholders.
KPMG Washington Healthcare Update
OCTOBER 3
The latest edition of KPMG Washington Healthcare Update examines matters on Capitol Hill, healthcare IT initiatives and matters dealing with HHS and CMS.
KPMG FlashPoint on Healthcare Reform
SEPTEMBER 25
The latest edition of FlashPoint on Healthcare Reform focuses on the most recent reform legislation and a side-by-side comparison of proposed healthcare plans by Senators McCain and Obama.
The Tablet: KPMG's Views on Regulating Sales and Promotional Compliance
SEPTEMBER 18
Drug companies face global regulatory pressure and public scrutiny in their interactions with healthcare professionals.
Weak Dollar, Declining Payments Make Japan's Drug Makers Go Abroad
SEPTEMBER 11
Japanese drug makers have taken advantage of the decline in the dollar to snatch up American pharmaceutical and biotech firms.
Revenue Recognition Tops Drug Company IFRS Concerns
AUGUST 25
For American drug firms, the transition to IFRS means changes in accounting for revenue from licensing deals.
Audit Committees a Catalyst for Vetting Risks in Recessionary Times
AUGUST 20
In the face of a possible recession, audit committees must also face recession-related risks like liquidity and the credit crunch.
|
